Evidence map›Paper›PMID 36375970›Full record

Observational studyBMJ open2022

Consequences of SARS-CoV-2 pandemic on urological surgery in France: a nationwide analysis of the healthcare system database.

Gregoire Robert, Jean-Christophe Bernhard, Grégoire Capon, Eric Alezra, Vincent Estrade, Peggy Blanc, Franck Bladou, Henri Bensadoun

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Measuring hospital care resilience: a systematic literature review.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gregoire RobertDepartment of Urology, CHU de Bordeaux, Bordeaux, France gregoire.robert@chu-bordeaux.fr.ORCID 0000-0001-5249-8689
Jean-Christophe BernhardDepartment of Urology, CHU de Bordeaux, Bordeaux, France.
Grégoire CaponDepartment of Urology, CHU de Bordeaux, Bordeaux, France.
Eric AlezraDepartment of Urology, CHU de Bordeaux, Bordeaux, France.
Vincent EstradeDepartment of Urology, CHU de Bordeaux, Bordeaux, France.
Peggy BlancDepartment of Urology, CHU de Bordeaux, Bordeaux, France.
Franck BladouDepartment of Urology, CHU de Bordeaux, Bordeaux, France.
Henri BensadounDepartment of Urology, CHU de Bordeaux, Bordeaux, France.
Centre Hospitalier Universitaire de Bordeaux · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 outbreak overwhelmed the healthcare systems worldwide. Saturation of hospitals and the risk of contagion led to a reduction in the care of other diseases.

objectiveTo determine the impact of SARS-CoV-2 pandemic on urological surgery in France during the year 2020. DESIGN, SETTING AND

participantsAn observational descriptive study was conducted on anonymised data collected from the national healthcare database established each year as part of the Program for the Medicalization of Information Systems in Medicine, Surgery, Obstetrics and Odontology.

interventionNone. PRIMARY AND SECONDARY OUTCOME MEASURES: We gathered the number of urology surgical procedures carried out between 2010 and 2019, and we observed the difference between the forecast and actual number of urological surgeries performed in 2020.

resultsUrological surgeries decreased by 11.4%, non-oncological surgeries being more affected (-13.1%) than oncological ones (-4.1%). Among the most relevant surgeries, female urinary incontinence (-44.7%) and benign prostatic hyperplasia (-20.8%) were the most impacted ones, followed by kidney cancer (-9%), urolithiasis (-8.7%), radical cystectomy for bladder cancer (-6.1%), prostate cancer (-3.6%) and transurethral resection of bladder tumour (-2%). Public hospitals had a more reduced activity (-17.7%) than private ones (-9.1%). Finally, the distribution of the reduction in urological activities by region did not correspond to the regional burden of SARS-CoV-2.

conclusionsUrological care was severely affected during SARS-CoV-2 pandemic. Even if oncological surgeries were prioritised, the longer it takes to receive appropriate care, the greater the risk on survival impact.

trial registrationThe data collection and analysis was authorised by the French Data Protection Authority (CNIL) under the number1 861 282v2.

Indexed as

COVID-19UrologyDelivery of Health CareFemaleHumansMalePandemicsSARS-CoV-2Adult oncologyCOVID-19UROLOGY

Identifiers

PMID36375970
PMCPMC9664026
OpenAlexW4308981384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.